DF/HCC CalendarThyme 1.3
© 2006 eXtrovert Software LLC. All rights reserved.
Don't forget to vote!
Not all places in the U.S. observe daylight time. In particular, Arizona, Hawaii, and most of Indiana do not use it.
Learn to use the NCBI MapViewer to generate useful analytical views of genomes, expression data, variation resources, and more. Discover how MapViewer can serve as an entry point for other NCBI resources such as the Sequence Viewer and the Evidence Viewer.
Allan Halpern, MD, Memorial Sloan Kettering Cancer Center, Department of Dermatology Please remember that the lecture takes place in the Simches Conference Center 185 Cambridge Street, 3rd floor, Room 3110 from 9am-10am. This is a locked facility and requires a Partners or Harvard ID for entrance. Please contact me advance of the lecture if you need access. SAVE THE DATE!
HSCI Stem Cell Symposium Friday, November 6, 2009 Harvard Club of Boston Click here for the event's website and link to registration (includes a scientific poster session) November 6‑8, 2009 Offered by: Dana‑Farber Cancer Institute Course Director: Kenneth D. Miller, MD Co‑Directors Larissa Nekhlyudov, MD, MPH and Richard Boyajian, NP
November 6‑8, 2009 Offered by: Dana‑Farber Cancer Institute Course Director: Kenneth D. Miller, MD Co‑Directors Larissa Nekhlyudov, MD, MPH and Richard Boyajian, NP Call for Abstracts - due October 5 to Kaitlin_Ostrander@DFCI.HARVARD.EDU Early Registration ends October 15
Beth Israel Deaconess Medical Center, Hematology/Oncology Grand Rounds Speaker: Professor Bernhard Lammle, MD Topic: "Thrombotic Thrombocytopenic Purpura: A Disease with More Researchers than Patients" This course will provide gynecologists, primary care physicians, nurse practitioners, and other interested clinicians with an update on developments in diagnosing and treating gynecologic cancers. Attendees will learn about updates in evaluating PAP smears, new approaches for treating gynecologic malignancies, and genetic risk and prevention factors for ovarian cancer. Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education. Harvard Medical School designates this educational activity for a maximum of 2.75 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For complete course information, and to register, visit: http://www.dfbwcc.org/classes/2009-11-07.html The HMS Office for Diversity & Community Partnership is pleased to invite you to attend Native American Health Forum - “Diabetes and Health Policy in American Indian Communities” followed by the video: “Unnatural Causes: Bad Sugar” Please see the attached flier for more information. VASCULAR BIOLOGY SEMINAR SERIES October 22, 2009 4:30 PM Speaker: ANDREW LICHTMAN, MD, PhD Professor of Pathology, Harvard Medical School Department of Pathology, Brigham and Women's Hospital Title: “Regulation of T Cell Immunity in the Cardiovascular System” Enders Auditorium Please join us for the 2009 Isner Lecture:
“Gene Therapy – Mediated Reversal of Congenital Blindness” Tufts University School of Medicine is pleased to welcome Jean Bennett, M.D., Ph.D., an internationally recognized leader in retinal gene therapy, as the presenter of the 2009 Jeffrey M. Isner, M.D. Endowed Memorial Lectureship. Dr. Bennett’s ground-breaking research in gene transfer approaches established the scientific underpinnings which made it possible to test the first potential definitive retinal gene therapy treatment for patients with blinding retinal degenerations. Please join us for this inspiring presentation! Speaker: Jean Bennett, M.D., Ph.D. F.M. Kirby Professor and Vice Chair of Research Department of Ophthalmology Professor, Cell and Developmental Biology University of Pennsylvania Scientist, Center for Cellular and Molecular Therapeutics The Children’s Hospital of Philadelphia 4th Annual Jeffrey M. Isner Endowed Memorial Lectureship Wednesday, November 4, 2009 4 pm Behrakis Auditorium Tufts University School of Medicine Reception to follow RSVP to Karolina Wrobel; karolina.wrobel@tufts.edu Tufts University School of Medicine Office of Alumni Relations p: 617.636.6770 We will host Abraxis Bioscience on November 5th in our DF/HCC Pipelines in Oncology Series - we will have 1:1 meetings at MGH in the morning (8-11 AM , Lawrence House 2nd floor ), followed by a lunchtime presentation at DFCI in Mayer 660, and additional 1:1 meetings at DFCI (1:30 - 5PM , Room TBD ) in the afternoon. Please let me know if you are available on November 5th to meet with the group from Abraxis and what time would be best within the time frame provided. Please RSVP for the Noon Presentation at Dana Farber if you are planning to attend. Presenting for Abraxis are Jose Iglesias, MD - CMO and VP for Global Clinical Development and David Brooks, MD, PhD - Medical Director for Global Clinical Development. Programs presented include: “Nab-paclitaxel®; ABI-008 (nab®-docetaxel); ABI-009 (nab®-rapamycin); ABI-010 (nab®-17AAG - Hsp90 inhibition); ABI-011 (nab®-dual mechanism inhibitor - microtubule destabilization and topo-1 inhibition) and ABI-0013 (nab®-novel taxane). Best Regards, Breast SPORE Research in Progress Meeting
"Cancer Serology Comes of Age: Proteomics for Cancer Detection and Prognosis" Karen Anderson, M.D. , Ph.D. Instructor, Department of Medicine - HMS Instructor in Medicine, Hematology/Oncology - DFCI Tuesday, November 3, 2009 5:30pm SM308/309 DFCI Friday, November 6, 2009 10:30 am - 11:30 am Pathology Conference Room Brigham and Women's Hospital Amory 3 CONFERENCE TITLE: Improved Adoptive Immunotherapy for EGFRvIII expressing glioblastoma through '3rd generation' chimeric receptor engineered T cells Ayguen Sahin, PhD Instructor at Harvard Medical School MGH-HMS Center for Nervous System Repair Department of Neurosurgery Breast Cancer in the
Developing World: Meeting the Unforeseen Challenge to Women, Health and Equity November 3-5, 2009 Longwood Medical Area Register at: www.hsph.harvard.edu/breastandhealth/ Open to the Harvard Community Questions? breastandhealth@harvard.edu Please note: If you registered previously, prior to the posting of workshops on the website, kindly re-register and sign-up for the workshop(s) that you would like to attend. These are now included in the registration process. Dates & Venues: November 3-5, 2009, Longwood Medical Area, Boston, Massachusetts Tuesday, November 3 (13:00-19:30) Brigham and Women's Hospital, 1620 Tremont Street, Roxbury Crossing, MA Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA Pre-conference workshops. Pre-registration is required. Seating is limited. Wednesday, November 4 (full day beginning at 9:00) Joseph B. Martin Conference Center, Harvard Medical School 77 Avenue Louis Pasteur, Boston, MA 02115. Plenary sessions and lunch event. Pre-registration is recommended (but not required) for plenary sessions. Pre-registration is required for the lunch. Seating is limited for opening session, keynote and lunch. Thursday, November 5 (full day beginning at 9:00) Dana-Farber Cancer Institute, Jimmy Fund Auditorium 44 Binney St. Boston, MA 02115. Plenary sessions and workshops. Pre-registration is recommended (but not required) for plenary sessions. Pre-registration is required for workshops. Seating is limited. Conference Overview: The conference will be opened by Jeffrey Flier, Dean of the Faculty of Medicine at Harvard Medical School; by Felicia Knaul, Director of the Harvard Global Equity Initiative; by Her Excellency Madam Tobeka Madiba Zuma, First Lady, The Republic of South Africa and Vice Chairperson, Forum of African First Ladies Against Breast & Cervical Cancer; by HRH Princess Dina Mired, Director General, King Hussein Cancer Foundation and Honorary Chairperson, National Breast Cancer Committee, Hashemite Kingdom of Jordan; by Lawrence Shulman, Chief Medical Officer and Senior Vice President for Medical Affairs, Dana-Farber Cancer Institute; and by Drew Gilpin Faust, President of Harvard University. The opening keynote address will be delivered by Amartya Sen, Nobel Laureate in Economics, and Thomas W. Lamont University Professor and Professor of Economics and Philosophy of Harvard University. A video address will be delivered by Margaret Chan, Director-General, World Health Organization. Confirmed speakers include: Ambassador Nancy G. Brinker, Susan G. Komen for the Cure and World Health Organization; Julio Frenk, Dean, Harvard School of Public Health, T & G Angelopoulos Professor of Public Health and International Development at the Harvard School of Public Health and Harvard Kennedy School, and former Minister of Health of Mexico; Lawrence Shulman, Chief Medical Officer and Senior Vice President for Medical Affairs, Dana-Farber Cancer Institute; Geeta Rao Gupta, President, International Center for Research on Women; Marina A. Njelekela, Chairperson, Medical Women's Association of Tanzania; Alejandro Mohar Betancourt, Director, National Cancer Institute of Mexico; Peter Piot, Director, Institute for Global Health, Imperial College London and former Executive Director, UNAIDS; and, John Seffrin, CEO, American Cancer Society. Conference Steering Committee: Flavia Bustreo, MD Director, Partnership for Maternal Newborn and Child Health-Secretariat World Health Organization Alessandra Durstine Vice President of Regional Strategies, International Affairs Department American Cancer Society Paul Farmer, MD, PhD Presley Professor and Chair, Department of Global Health and Social Medicine, Harvard Medical School Chief, Division of Global Health Equity, Brigham and Women's Hospital Co-founder, Partners In Health Julio Frenk, MD, MPH, PhD Dean, Harvard School of Public Health T & G Angelopoulos Professor of Public Health and International Development, Harvard School of Public Health and Harvard Kennedy School Mary Gospodarowicz, FRCPC, FRCR, MD Professor and Chair, Department of Radiation Oncology, University of Toronto Medical Director of the Oncology Program and Chief of the Radiation Medicine Program, Princess Margaret Hospital Julie Gralow, MD Director of Breast Medical Oncology, Seattle Cancer Care Alliance Professor, University of Washington School of Medicine Paula Johnson, MD, MPH Executive Director, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital Associate Professor of Medicine, Harvard Medical School Felicia Marie Knaul, PhD (conference organizer) Director, Harvard Global Equity Initiative Associate Professor of Medicine and Social Medicine, Harvard Medical School Founder, "Cáncer de mama: Tómatelo a Pecho" Ana Langer, MD President and Chief Executive Officer, EngenderHealth Lawrence Shulman, MD Chief Medical Officer and Sr. Vice-President for Medical Affairs, Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School Sponsors include (in addition to the institutions represented by the steering committee) Fred Hutchinson Cancer Research Center; Susan G. Komen for the Cure; and International Development Research Center, Canada. Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors On behalf of the organizers, we would like to invite you to attend the 9th Frye Halloran Symposium at Massachusetts General Hospital. On November 5-6, 2009, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors. We invite you to attend this tuition-free meeting. Speakers will address molecular targets of cancers of lung, breast and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung cancer and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents. The Symposium will be of interest to Medical Oncologists, Clinical Neuro-Oncologists, specialists in studies of ‘designer’ drugs, scientists working in molecular pathways as well as molecular epidemiologists, clinical trialists and pathologists.We ask that you explore our Website http://fh2009.neurosuite.org for more information. If you wish to attend this free symposium please register on the website or contact Rita Gould at (617) 726-8657 or rgould2@partners.org.
Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors On behalf of the organizers, we would like to invite you to attend the 9th Frye Halloran Symposium at Massachusetts General Hospital. On November 5-6, 2009, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors. We invite you to attend this tuition-free meeting. Speakers will address molecular targets of cancers of lung, breast and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung cancer and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents. The Symposium will be of interest to Medical Oncologists, Clinical Neuro-Oncologists, specialists in studies of ‘designer’ drugs, scientists working in molecular pathways as well as molecular epidemiologists, clinical trialists and pathologists.
We ask that you explore our Website http://fh2009.neurosuite.org for more information. If you wish to attend this free symposium please register on the website or contact Rita Gould at (617) 726-8657 or rgould2@partners.org. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||